Comparing two treatments for Crohn's disease strictures
Part of Digestive system clinical trials.
This trial compares two ways to treat narrowed areas (strictures) in the gut caused by Crohn's disease: endoscopic strictureplasty versus balloon dilation. It aims to see which method works better for people whose strictures are manageable with a scope.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a Crohn's disease stricture (narrowing) that can be seen on imaging and reached with a colonoscope.
- If you've had endoscopic treatment before, you must have been symptom-free for at least one year.
- You have partial or complete bowel blockage, and standard treatments haven't worked well.
- The narrowing is less than 5 cm long, and you have no more than two narrowed areas.
- You do not have an abscess, fistula, or active inflammation outside the stricture, and no condition that prevents the procedure or poses high bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two timing choices for surgery in people with Crohn’s disease who have bowel narrowing (strictures) causing blockage symptoms. The goal is to see whether operating earlier leads to better control of symptoms and inflammation when other treatments haven’t worked.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This study looks at treatments for a new (de novo) narrow area in the bowel from Crohn’s disease. It aims to see which treatment works better at relieving blockage-type symptoms for the safest, most effective option.
This study compares a medical treatment approach versus surgery for people with Crohn’s disease that causes narrowing (strictures) in the small intestine and blocking symptoms. It aims to see which approach works better in easing symptoms and preventing problems from the narrowing.
This trial tests whether adding a platelet-rich plasma (PRP) injection to the standard balloon dilation procedure can help treat a narrowed section of the colon caused by Crohn's disease. It may offer a way to avoid or delay surgery for some patients.
This trial tests ustekinumab, a medicine that calms immune inflammation, to see if it can improve symptoms in people with Crohn’s disease that causes bowel narrowing. It may help if your Crohn’s symptoms come from strictures (narrowed areas) seen on scans or endoscopy.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.